Company Filing History:
Years Active: 2022
Title: Regina Aharonov-Nadborny: Innovator in Non-Invasive COVID-19 Detection
Introduction
Regina Aharonov-Nadborny is a prominent inventor based in Beit Arye, Israel. She has made significant contributions to the field of medical technology, particularly in the detection of viral infections. Her innovative approach focuses on non-invasive methods, which are crucial in today's health landscape.
Latest Patents
Regina holds a patent for "Systems and methods for non-invasive determination of COVID-19 coronavirus infection." This patent describes a high throughput method for label-free, non-contact, non-invasive, and nondestructive detection of individuals infected with the virus. The method involves collecting a sample from the exhaled breath of a subject, which is analyzed to determine if the individual is infected. The process includes using a metamaterial membrane to collect aerosols and airborne compounds from the exhaled breath, enhancing the accuracy of the detection.
Career Highlights
Regina Aharonov-Nadborny has established herself as a key figure in her field. She works at Terahertz Group Ltd., where she collaborates with other talented professionals. Her work is characterized by a commitment to advancing medical technology and improving public health outcomes.
Collaborations
Regina has worked alongside notable colleagues, including Eran Gabbai and Yaniv Maydar. Their combined expertise contributes to the innovative projects at Terahertz Group Ltd.
Conclusion
Regina Aharonov-Nadborny is a trailblazer in the realm of non-invasive medical detection technologies. Her patent for COVID-19 detection exemplifies her dedication to innovation and public health. Through her work, she continues to make a significant impact in the fight against viral infections.